XML 77 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Segment Information
12 Months Ended
Oct. 31, 2012
Segment Reporting [Abstract]  
Business Segment Information
Business Segment Information
Cooper uses operating income, as presented in our financial reports, as the primary measure of segment profitability. We do not allocate costs from corporate functions to segment operating income. Items below operating income are not considered when measuring the profitability of a segment. We use the same accounting policies to generate segment results as we do for our consolidated results.

Total net sales include sales to customers as reported in our Consolidated Statements of Income and sales between geographic areas that are priced at terms that allow for a reasonable profit for the seller. Operating income (loss) is total net sales less cost of sales, research and development expenses, selling, general and administrative expenses, restructuring costs and amortization of intangible assets. Corporate operating loss is principally corporate headquarters expense. Loss on extinguishment of debt; other income (expense), net and interest expense are not allocated to individual segments. Neither of our business segments relies on any one major customer.
Identifiable assets are those used in continuing operations except cash and cash equivalents, which we include as corporate assets. Long-lived assets are property, plant and equipment.

The following table presents a summary of our business segment net sales:
(In thousands)
2012
 
2011
 
2010
CooperVision net sales by category:
 
 
 
 
 
Toric lens
$
357,211

 
$
339,184

 
$
292,732

Multifocal lens
94,443

 
74,741

 
71,603

Single-use sphere lens
267,090

 
243,624

 
207,250

Non single-use sphere and other eye care products and other
470,500

 
463,589

 
398,898

Total CooperVision net sales
1,189,244

 
1,121,138

 
970,483

CooperSurgical net sales
255,892

 
209,697

 
188,034

Total net sales
$
1,445,136

 
$
1,330,835

 
$
1,158,517



Information by business segment for each of the years in the three-year period ended October 31, 2012, follows:
(In thousands)
CooperVision
 
CooperSurgical
 
Corporate &
Eliminations
 
Consolidated
2012
 
 
 
 
 
 
 
Net sales
$
1,189,244

 
$
255,892

 
$

 
$
1,445,136

Operating income (loss)
$
262,806

 
$
58,956

 
$
(38,364
)
 
$
283,398

Other income, net
 
 
 
 
 
 
229

Interest expense
 
 
 
 
 
 
(11,771
)
Gain on insurance proceeds
 
 
 
 
 
 
5,000

Loss on extinguishment of debt
 
 
 
 
 
 
(1,404
)
Income before income taxes
 
 
 
 
 
 
$
275,452

Identifiable assets
$
2,251,476

 
$
607,673

 
$
82,235

 
$
2,941,384

Depreciation expense
$
82,829

 
$
4,106

 
$
300

 
$
87,235

Amortization expense
$
15,578

 
$
8,401

 
$

 
$
23,979

Capital expenditures
$
92,459

 
$
6,647

 
$
673

 
$
99,779

2011
 
 
 
 
 
 
 
Net sales
$
1,121,138

  
$
209,697

  
$

 
$
1,330,835

Operating income (loss)
$
207,485

  
$
52,420

  
$
(32,349
)
 
$
227,556

Other expense, net
 
 
 
 
 
 
(963
)
Interest expense
 
 
 
 
 
 
(17,342
)
Loss on extinguishment of debt
 
 
 
 
 
 
(16,487
)
Income before income taxes
 
 
 
 
 
 
$
192,764

Identifiable assets
$
2,206,068

  
$
354,020

  
$
64,430

 
$
2,624,518

Depreciation expense
$
74,146

  
$
3,264

  
$
210

 
$
77,620

Amortization expense
$
14,245

  
$
6,284

  
$

 
$
20,529

Capital expenditures
$
97,131

  
$
6,287

  
$
247

 
$
103,665

2010
 
 
 
 
 
 
 
Net sales
$
970,483

  
$
188,034

  
$

 
$
1,158,517

Operating income (loss)
$
171,345

  
$
47,064

  
$
(28,497
)
 
$
189,912

Other expense, net
 
 
 
 
 
 
(1,068
)
Interest expense
 
 
 
 
 
 
(36,668
)
Litigation settlement charges
 
 
 
 
 
 
(27,750
)
Income before income taxes
 
 
 
 
 
 
$
124,426

Identifiable assets
$
2,141,685

  
$
328,931

  
$
54,402

 
$
2,525,018

Depreciation expense
$
72,717

  
$
2,913

  
$
315

 
$
75,945

Amortization expense
$
12,361

  
$
5,695

  
$

 
$
18,056

Capital expenditures
$
69,793

  
$
3,871

  
$
93

 
$
73,757



Information by geographical area by country of domicile for each of the years in the three-year period ended October 31, 2012, follows:
 
(In thousands)
United
States
  
Europe
 
Rest of
World, Other
Eliminations
& Corporate
 
Consolidated
2012
 
  
 
 
 
 
 
Sales to unaffiliated customers
$
680,757

  
$
408,813

 
$
355,566

 
$
1,445,136

Sales between geographic areas
198,593

  
318,196

 
(516,789
)
 

Net sales
$
879,350

  
$
727,009

 
$
(161,223
)
 
$
1,445,136

Operating income
$
44,977

  
$
5,367

 
$
233,054

 
$
283,398

Long-lived assets
$
371,314

  
$
261,269

 
$
7,672

 
$
640,255

2011
 
  
 
 
 
 
 
Sales to unaffiliated customers
$
627,438

  
$
392,152

 
$
311,245

 
$
1,330,835

Sales between geographic areas
172,618

  
304,585

 
(477,203
)
 

Net sales
$
800,056

  
$
696,737

 
$
(165,958
)
 
$
1,330,835

Operating income
$
37,113

  
$
18,703

 
$
171,740

 
$
227,556

Long-lived assets
$
373,211

  
$
226,665

 
$
9,329

 
$
609,205

2010
 
  
 
 
 
 
 
Sales to unaffiliated customers
$
568,786

  
$
345,970

 
$
243,761

 
$
1,158,517

Sales between geographic areas
143,951

  
300,948

 
(444,899
)
 

Net sales
$
712,737

  
$
646,918

 
$
(201,138
)
 
$
1,158,517

Operating income
$
57,776

  
$
(4,935
)
 
$
137,071

 
$
189,912

Long-lived assets
$
357,200

  
$
227,780

 
$
8,907

 
$
593,887